Study of Pomegranate Juice in the Modulation of Oxidative Stress Markers in Endurance-based Athletes
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
The purpose of this study is to evaluate modifications of plasma protein carbonyls and malondialdehyde levels in endurance-based athletes after three weeks of pomegranate juice consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1
Started Aug 2012
Shorter than P25 for early_phase_1
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 10, 2014
CompletedFirst Posted
Study publicly available on registry
November 18, 2014
CompletedNovember 18, 2014
November 1, 2014
4 months
November 10, 2014
November 13, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Protein carbonyls levels changes in plasma
Protein carbonyl derivatives were determined using an adaptation of the colorimetric method published in Levine et al. (1994) based in the formation of a stable 2,4-dinitrophenyl (DNP) hydrazone product after the addition of 2,4-dinitrophenylhydrazine (DNPH) to tha plasma. Protein carbonyls were calculated as nmoles·mg-1 protein
day 0 and 22
Malondialdehyde levels changes in plasma
Malondialdehyde was determined by high pressure liquid chromatography (HPLC) with fluorescence detection according to the method described by Laporta et al. (2007). Malondialdehyde levels were calculated as nmoles·g-1 protein
day 0 and 22
Secondary Outcomes (3)
Blood biochemical parameters changes in plasma
day 0 and 22
C-reactive protein levels changes in plasma
day 0 and 22
Soluble E-selectin levels changes in plasma
day 0 and 22
Study Arms (3)
Control
NO INTERVENTIONArm that followed all the protocols with the exception of the pomegranate juice intake.
Pomegranate Juice
EXPERIMENTALArm that followed all the protocols and the pomegranate juice intake.
Pomegranate Juice Dilution
EXPERIMENTALArm that followed all the protocols and the pomegranate juice dilution (1:1) intake.
Interventions
Intake of 200 ml of pomegranate juice or pomegranate juice dilution during 21 days after exercise.
Eligibility Criteria
You may qualify if:
- Perform specific endurance training sessions
- More than 1 hour per session and more than 3 sessions per week
- Have participated recently in a half marathon or similar event
You may not qualify if:
- Intake of antioxidant or anti-inflammatory supplementation
- Present a chronic disorder
- Non-smoker
- No-alcoholic beverage consumption
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad Miguel Hernandez de Elchelead
- Vitalgrana Pomegranate SLcollaborator
Related Publications (2)
Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000 May;71(5):1062-76. doi: 10.1093/ajcn/71.5.1062.
PMID: 10799367RESULTTrombold JR, Reinfeld AS, Casler JR, Coyle EF. The effect of pomegranate juice supplementation on strength and soreness after eccentric exercise. J Strength Cond Res. 2011 Jul;25(7):1782-8. doi: 10.1519/JSC.0b013e318220d992.
PMID: 21659887RESULT
Study Officials
- STUDY DIRECTOR
Enrique Roche, PhD
University Miguel Hernández
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
November 10, 2014
First Posted
November 18, 2014
Study Start
August 1, 2012
Primary Completion
December 1, 2012
Study Completion
February 1, 2013
Last Updated
November 18, 2014
Record last verified: 2014-11